Search For "chimeric antigen receptor"
ImmunoACT announces partnership with Mango Sciences to bring the world's f
Updated : 5 months, 4 weeks ago IST
Mumbai (Maharashtra) [India], December 2: ImmunoAdoptive Cell Therapy (ImmunoACT), the Mumbai, India-based pioneering research and cell and gene therapy development company, announced a strategic partnership with Mango Sciences, Inc., the Boston, US, and Bengaluru, IN-based data and AI compa
Read More
Safdarjung Hospital performs its first-ever (CAR) T-cell therapy to treat
Updated : 1 year, 4 months ago IST
The VMMC and Safdarjung Hospital has successfully performed its first-ever Chimeric Antigen Receptor T-cell (CAR-T) therapy under the leadership of Prof. Sandeep Bansal (Medical Superintendent), a novel treatment for certain types of lymphoma and blood cancers.
Read More
Promising cell therapy offers hope for relapsed or refractory T-Cell Leuka
Updated : 1 year, 7 months ago IST
Singapore, October 5: A new cell therapy, targeting CD7 on leukaemia cells, gives a potentially effective treatment for patients with T-cell acute lymphoblastic leukaemia (T-ALL) who have exhausted all standard treatment options. Published in the prestigious medical journal Nature Medicine o
Read More
Patients with blood cancer benefit from CAR T-cell therapy: Study
Updated : 2 years, 7 months ago IST
Patients with multiple myeloma who received idecabtagene vicleucel, popularly known as "ide-cel," a chimeric antigen receptor (CAR) T-cell treatment, had no difference in overall survival outcomes regardless of race or ethnicity.
Read More
CAR T-cell treatment is beneficial in patients with blood cancer: Study
Updated : 2 years, 7 months ago IST
According to a study published in Blood Advances, patients with multiple myeloma who received idecabtagene vicleucel, also known as "ide-cel," a chimeric antigen receptor (CAR) T-cell treatment, exhibited no change in overall survival outcomes regardless of race or ethnicity.
Read More
Study reveals some effective cancer treatments improve quality of life
Updated : 3 years, 2 months ago IST
Despite the fact that chimeric antigen receptor T-cell (CAR-T) therapy has transformed cancer treatment, few studies have looked into its impact on long-term patient quality of life - an aspect of care that is frequently compromised when patients receive traditional intensive cancer medicati
Read More
Researchers discover source of T cell exhaustion
Updated : 3 years, 2 months ago IST
CAR T-cell treatments, which are specifically designed to target cancer cells, has heralded a new era in the treatment of human cancers, particularly hematologic malignancies. But all too frequently, they exhibit a disconcerting characteristic derived from the immune system's own cells: a sh
Read More
Study suggests new type of immunotherapy for ovarian cancer patients
Updated : 3 years, 3 months ago IST
CAR T-cell therapy, a sort of cancer treatment in which the immune system's T cells are trained to attack tumour cells, was found to be effective in mice with ovarian cancer, according to a study.
Read More
Researchers reveal how new type of immunotherapy for ovarian cancer
Updated : 3 years, 3 months ago IST
According to a study, CAR T-cell therapy, a type of cancer treatment in which the immune system's T cells are trained to attack tumour cells, is successful in mice with ovarian cancer.
Read More
First clinical trial of anticancer drug 'CAR-T' is underway for lymphoma p
Updated : 4 years, 7 months ago IST
Seoul [South Korea], October 21 (ANI/Global Economic): An anticancer treatment 'CAR-T (chimeric antigen receptor T-cell),' called a miracle anticancer drug, has been developed and the first clinical trial in Korea is being conducted.
Read More
Antibiotics influence cancer treatment efficacy
Updated : 8 years, 2 months ago IST
Washington D.C. [U.S.A.], Mar. 03 (ANI): Turns out, antibiotics may impact cancer treatment efficacy.
Read More